high definition diagnostics℠

Technology Designed to Reveal More

Simoa's revolutionary digital approach to immunoassays allows single molecules to be counted, delivering a roughly 1000-fold increase in sensitivity. This remarkable sensitivity combined with full automation unlocks a world of insight into disease detection, diagnosis, and patient treatment while meeting the demands of today's laboratory.


Watch the Simoa video to learn more


Unprecedented Sensitivity

1000 times greater sensitivity than conventional immunoassays.
Learn More.


Robust Multiplexing

Improve efficiencies and stretch samples with up to 10-plex assays.
Learn More.


Complete Automation

Sample in, result out with an intuitive, user-friendly interface.
Learn More.


Quanterix News

  • Quanterix one of 33 Recipients of Massachusetts Life Sciences Center Tax Incentive Award

    Monday, 21 April 2014

    Quanterix announced that they have been selected as one of the 33 recipients of the Massachusetts Life Sciences Center tax awards.

    Read More

  • Quanterix Awarded Grant from GE and the NFL’s Head Health Challenge

    Friday, 21 March 2014

    Quanterix announced that they have been selected as a winner of the GE and NFL Head Health Challenge from more than 400 entries across 27 countries by a panel of leading healthcare experts in brain research, imaging technologies and advocates for the advancement of brain research.This grant provides funding to help further advance development of tests to quickly diagnose traumatic brain injuries through their ultra-sensitive Simoa™technology that measures molecular signatures (biomarkers) of brain injury in blood.

    Read More